好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Good Communicators Are Not Stronger Performers on OSCEs: Neurology Resident Performance on a Communication Skills Station Is Not Related to Overall Objective Standardized Clinical Examination (OSCE) Performance
Neurologic 好色先生
P04 - (-)
254
BACKGROUND: People with stronger communication skills may be viewed as being competent through their ability to verbalize answers. Neurology resident competency is examined through the objective standardized clinical examination (OSCE): an accepted method of resident evaluation. To our knowledge, communication skills performance has not been correlated with performance on other OSCE stations examining medical knowledge and application.
DESIGN/METHODS: We retrospectively examined neurology resident performance on OSCEs for neurology residents (R3 to 5) from 3 Canadian universities in one OSCE. The Communication station systematically examined verbal communication of residents, observing resident communication to a standardized patient. Other OSCE stations examined medical knowledge and application. Residents who scored 90% or higher in communication station were designated excellent communicators. A total performance score was created by adding the raw scores of all OSCE stations together. Independent samples t-tests were used to compare total score in excellent communicators versus other residents.
RESULTS: Of 25 residents attending the OSCE, 13 were designated excellent communicators. The mean total score was higher in excellent communicators (187.1, SD 26.7) than other residents (179.4, SD 23.8) however this difference was not statistically significant (p = 0.454). Excellent communicators had a higher score on the pediatrics station than other residents (12.6, SD 6.1 vs 8.8, SD 5.3) but this difference was not statistically significant (p= 0.10). Our study had 80% power to detect a 15% difference between total scores.
CONCLUSIONS: We did not find a relationship between performance on an OSCE communication station and overall OSCE performance. This supports the conclusion that OSCEs are able to assess competence in neurology trainees with varied communication skills.
Authors/Disclosures
Penelope S. Smyth, MD (University of Alberta)
PRESENTER 		Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Smyth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Canada. Dr. Smyth has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Short Term Exceptional Drug Therapy Program Alberta. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen-Idec. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Pharmaceuticals.
Valerie Sim, MD, BSc (University of Alberta) The institution of Dr. Sim has received research support from CJD Foundation. The institution of Dr. Sim has received research support from National Research Council of Canada Nanotechnology Research Centre. The institution of Dr. Sim has received research support from Alberta Innovates. The institution of Dr. Sim has received research support from Alzheimer Society of Canada. The institution of Dr. Sim has received research support from ALS Canada / Brain Canada. The institution of Dr. Sim has received research support from Results Driven Agricultural Research. Dr. Sim has received intellectual property interests from a discovery or technology relating to health care. Dr. Sim has received personal compensation in the range of $500-$4,999 for serving as a Clinical neurology consultant for human prion diseases with Public Health Agency of Canada.
Thomas J. Jeerakathil, MD, BSC (University of Alberta) The institution of Dr. Jeerakathil has received research support from University Hospital Foundation.
Teena Shetty, MD, FAAN (Hospital for Special Surgery) Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.